Sign inJoin waitlistJoin the waitlist

Sei Sze

Pediatrics

Credentials: · · · ·

History

Pediatric Hematology Oncology
Duke University Hospital
2014–2017
Pediatrics
Yale Univ Sch of Med
2011–2014
Univ of Rochester Sch of Med & Dent
2006–2010

Research

The SQSTM1-NUP214 fusion protein interacts with Crm1, activates Hoxa and Meis1 genes, and drives leukemogenesis in mice
PLoS ONE · 2020 · 10 citations
Neonatal Renal Tumors
Review · Clinics in Perinatology · 2021 · Sole author · 4 citations
Retrospective Diagnosis of Ataxia-Telangiectasia in an Adolescent Patient With a Remote History of T-Cell Leukemia
Case report · Journal of Pediatric Hematology/Oncology · 2021 · First of 9 authors · 2 citations

Daniel Wechsler
3 papers · 3 as a fellow
Veerain Gupta
2 papers
WA
Waitman Aumann
2 papers
Alyssa Kennedy
1 paper
AL
Amy Li
1 paper · 1 as a resident
HL
Howard Lederman
1 paper
JB
Jacob Bledsoe
1 paper
Jessica Heath
1 paper
KR
Katelyn Ripple
1 paper
Leslie Lehmann
1 paper
Malika Kapadia
1 paper
Michael Kastan
1 paper

Clinical trials

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2029
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Site PI · Recruiting · Phase 1, Phase 2
PedAL BCU, LLC
2022–2030